Laura Dyrda

Laura Dyrda

DePuy Synthes parent company Johnson & Johnson reported $18.3 billion in fourth quarter net sales — relatively flat over the same time last year — but full year sales reached $74.3 million, a 4.2 percent increase over the same period last year.

Stryker will open its new European Regional Headquarters to support business overseas, according to Today's Medical Development.

Do patients with diabetes have a higher reoperation rate after lumbar spine surgery?

Neel Anand, MD, a clinical professor of surgery and director of spine trauma at Cedars-Sinai Medical Center in Los Angeles, was featured in a HealthBeat report discussing spinal surgery.

Zimmer beat expectations for fourth quarter profit, but net sales decreased 1.4 percent over the previous year.

Stryker's 2014 earnings were down and missed expectations, but Chairman and CEO Kevin Lobo isn't panicking yet.

Do orthopedic surgeons use marijuana?

How does financial sponsorship impact spine device clinical trials? Can we trust multicenter prospective randomized clinical trials to present the best evidence?

The first adult patient to receive the MAGEC rod for scoliosis correction is showing improvement, according to a Daily Mail report.

Wednesday, 28 January 2015 00:00

OrthAlign grew 46% in 2014 — 5 things to know

OrthAlign exceeded total 2014 sales forecasts. 

  • «
  •  Prev 
  •  1 
  •  2 
  •  3 
  •  4 
  •  5 
  •  6 
  •  7 
  •  8 
  •  9 
  •  10 
  •  Next 
  • »
Page 1 of 727